LEILA SAHNI to Male
This is a "connection" page, showing publications LEILA SAHNI has written about Male.
Connection Strength
0.430
-
Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
Score: 0.023
-
Understanding the Financial Implications of Immunization Reminder/Recall in a Multipractice Pediatric Group. Acad Pediatr. 2017 04; 17(3):323-329.
Score: 0.020
-
Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 2015 Feb; 135(2):e432-9.
Score: 0.019
-
Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9.
Score: 0.016
-
Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
Score: 0.010
-
Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
Score: 0.010
-
Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
Score: 0.010
-
Acute Gastroenteritis Among Household Contacts of Children with Severe Norovirus Gastroenteritis, United States, 2011-2016. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
Score: 0.010
-
Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
Score: 0.010
-
Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019. J Clin Virol. 2025 Aug; 179:105822.
Score: 0.010
-
Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020. Influenza Other Respir Viruses. 2025 Jun; 19(6):e70124.
Score: 0.010
-
Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
Score: 0.009
-
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
Score: 0.009
-
Enterovirus D68-Associated Respiratory Illness in Children. JAMA Netw Open. 2025 05 01; 8(5):e259131.
Score: 0.009
-
The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children. J Pediatric Infect Dis Soc. 2025 Apr 08; 14(4).
Score: 0.009
-
Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
Score: 0.009
-
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 Feb 01; 179(2):179-187.
Score: 0.009
-
Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
Score: 0.009
-
Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020. JAMA Netw Open. 2024 12 02; 7(12):e2452512.
Score: 0.009
-
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
Score: 0.009
-
Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute Gastroenteritis. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):547-550.
Score: 0.009
-
On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network. Vaccine. 2024 12 02; 42(26):126455.
Score: 0.009
-
Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022. Pediatrics. 2024 Oct 01; 154(4).
Score: 0.009
-
Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems. Pediatr Infect Dis J. 2025 Jan 01; 44(1):47-53.
Score: 0.009
-
Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022. Pediatrics. 2024 Jul 01; 154(1).
Score: 0.009
-
Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024 04 01; 7(4):e248255.
Score: 0.009
-
Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5?Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019. J Pediatr. 2024 Aug; 271:114045.
Score: 0.009
-
Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 02 01; 6(2):e2254909.
Score: 0.008
-
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
Score: 0.008
-
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
Score: 0.008
-
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
Score: 0.007
-
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
Score: 0.007
-
Understanding Vaccine Hesitancy Among Parents of Children With Autism Spectrum Disorder and Parents of Children With Non-Autism Developmental Delays. J Child Neurol. 2021 09; 36(10):911-918.
Score: 0.007
-
Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study. Pediatrics. 2021 08; 148(2).
Score: 0.007
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
Score: 0.007
-
Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
Score: 0.007
-
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
Score: 0.007
-
Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):181-187.
Score: 0.007
-
Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open. 2019 09 04; 2(9):e1912242.
Score: 0.006
-
Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
Score: 0.006
-
Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. 2019 02; 143(2).
Score: 0.006
-
Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 09 01; 214(5):732-8.
Score: 0.005
-
Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 09; 43:338-42.
Score: 0.005
-
Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
Score: 0.005
-
Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015 Nov; 169(11):1040-5.
Score: 0.005
-
Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9.
Score: 0.005
-
The Texas Children's Hospital immunization forecaster: conceptualization to implementation. Am J Public Health. 2014 Dec; 104(12):e65-71.
Score: 0.005
-
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20.
Score: 0.004
-
Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9.
Score: 0.003
-
Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207.
Score: 0.003